✦ LIBER ✦

PDB16 THE COST-UTILITY AND BUDGET IMPACT ANALYSIS OF SITAGLIPTIN (JANUVIA®) IN TYPE 2 DIABETES IN POLAND

✍ Scribed by J Walczak; I Malczak; A Panasiuk; D Pawlik; K Lasota; J Stelmachowski; G Nogas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB14 THE BUDGET IMPACT ANALYSIS OF VILD

✍ J Walczak; G Nogas; E Gebus; D Pawlik; K Pacocha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

PDB18 THE COMPLICATIONS IMPACT ON DIABET

✍ MP Niewada; CA Glogowski; M Latek; A Pietrasik; B Kamiñski; JM Gierczynski; A Kr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

PDB28 THE COST-EFFECTIVENESS ANALYSIS OF

✍ J Walczak; G Nogas; E Gebus; D Pawlik; K Pacocha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB27 THE COST-EFFECTIVENESS OF INSULIN

✍ J Walczak; W Dardzinski; M Kusy; J Lis; G Nogas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PDB15 COMPARATIVE COST-UTILITY ANALYSIS

✍ J Walczak; D Pawlik; A Jasinska; M Garbacka; J Kedzior; T Fundament; I Malczak; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PDB16: COST OF TYPE 2 DIABETES CARE IN A

✍ S Colagiuri; B Conway; D Grainger; P Davey; R Colagiuri; P Graham-Clarke; P Fitz 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB